4D Molecular Therapeutics, Inc. (FDMT) earnings
Quarterly results of 4D Molecular Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
4D Molecular Therapeutics, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) 4D Molecular Therapeutics, Inc. reported revenue of $3.8M (+25,106.7% on the same quarter a year earlier) and a net loss of $72.9M.
Diluted earnings per share were -$1.04.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $3.8M | +25,106.7% | -$72.9M | -$1.04 |
| Q1 FY2026 | $3M | +21,664.3% | -$68.8M | -$1.01 |
| Q4 FY2025 | $85.1M | +8,508,900% | $19.4M | - |
| Q3 FY2025 | $90K | +2,900% | -$56.9M | -$1.01 |
| Q2 FY2025 | $15K | - | -$54.7M | -$0.98 |
| Q1 FY2025 | $14K | - | -$48M | -$0.86 |
| Q4 FY2024 | $1K | - | -$49.7M | - |
| Q3 FY2024 | $3K | - | -$43.8M | -$0.79 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
When is 4D Molecular Therapeutics, Inc.'s next earnings date?
4D Molecular Therapeutics, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.
What were 4D Molecular Therapeutics, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, 4D Molecular Therapeutics, Inc. reported revenue of $3.8M and a net loss of $72.9M. The figures come from its filing with the SEC.
Is 4D Molecular Therapeutics, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $3.8M, up 25,106.7% from $15K in the same quarter a year earlier.
Get an email when FDMT reports
Follow FDMT and we email you its next results the day they are filed, with the numbers explained.